First Financial Posts Record Q2 Net Income and $1.91 EPS, but Nonperforming Loans Triple
THFF sits 52% above its 52-week low of $51.21.
Summary
Record Q2 net income of $22.7 million ($1.91 EPS) was driven by strong loan growth and margin expansion, but nonperforming loans tripled year-over-year to $27.1 million, signaling emerging credit risk.
Key Events · Earnings and Guidance · THFF
-
Record Q2 Net Income
Net income reached $22.7 million, a 22% increase from $18.6 million in Q2 2025, with diluted EPS of $1.91 compared to $1.57.
-
Net Interest Income Hits Record
Net interest income climbed 16.2% to $61.2 million, as the net interest margin widened to 4.33% from 4.15%.
-
Nonperforming Loans Triple
Nonperforming loans jumped to $27.1 million (0.61% of loans) from $9.8 million (0.25%) a year ago, though the credit loss provision fell to $1.3 million from $2.0 million.
-
CedarStone Acquisition Completed
The acquisition closed on March 1, 2026, adding $292 million in loans and $313 million in deposits. A bargain purchase gain of $33 thousand was recognized after measurement period adjustments.
Analysis · THFF · Finance
A strong quarter delivered record net income and net interest income, fueled by loan growth and the CedarStone acquisition. Yet nonperforming loans surged to $27.1 million from $9.8 million a year ago—a red flag that warrants attention. The net interest margin expanded to 4.33%, and book value per share rose 14.6% to $56.83. The CedarStone Financial deal, which closed March 1, 2026, added $292 million in loans and $313 million in deposits, boosting the top line while introducing integration risk. The stock trades near its 52-week high, reflecting optimism, but the sharp rise in credit stress could temper that if it continues.
At the time of this filing, THFF was trading at $77.70 on NASDAQ in the Finance sector, with a market capitalization of approximately $923.6M. The 52-week trading range was $51.21 to $78.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.